Technical Analysis for AQST - Aquestive Therapeutics, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
 |
3.11 | -3.42% | -0.11 |
AQST closed down 3.42 percent on Friday, September 20, 2019, on 1.61 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
| ADX | Long-Term | Intermediate-Term | Short-Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| See historical AQST trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing Low | Bearish | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| Stochastic Reached Oversold | Weakness | 0.00% | |
| Below Lower BB | Weakness | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| 20 DMA Resistance | Bearish | -3.42% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -3.42% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -10.89% |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/04/2019
- Sector: Healthcare
- Industry: Biotechnology
Aquestive Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on the development of treatments for diseases related to the central nervous system (CNS). Its CNS programs consist of a pipeline of products that include Libervant, Sympazan, and AQST-117. Libervant is a buccal soluble film formulation of diazepam for the treatment of recurrent epileptic seizures. Sympazan is an oral soluble film formulation of clobazam for the treatment of seizures associated with a rare, intractable form of epilepsy known as Lennox-Gastaut Syndrome. AQST-117 is an oral soluble film formulation of riluzole for the treatment of Amyotrophic Lateral Sclerosis. The Company’s complex molecule programs consist of AQST-108, and AQST-305, for the treatment of anaphylaxis and neuroendocrine tumors respectively. The Company also has a pipeline of products under partner programs, which includes Suboxone and APL-130277 for the treatment of opioid dependence, and Parkinson’s disease.
Pharmaceutical Diseases Drugs Psychoactive Drugs Amyotrophic Lateral Sclerosis Epilepsy Chloroarenes Opioids Gabaa Receptor Positive Allosteric Modulators Lactams Parkinson’s Disease Neuroendocrine Tumors Riluzole
Pharmaceutical Diseases Drugs Psychoactive Drugs Amyotrophic Lateral Sclerosis Epilepsy Chloroarenes Opioids Gabaa Receptor Positive Allosteric Modulators Lactams Parkinson’s Disease Neuroendocrine Tumors Riluzole
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength | |||
| Summary: | Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies. | ||
See more AQST news...
Indicators
| Indicator | Value |
|---|---|
| 52 Week High | 18.49 |
| 52 Week Low | 2.96 |
| Average Volume | 92,702 |
| 200-Day Moving Average | 5.51 |
| 50-Day Moving Average | 3.6998 |
| 20-Day Moving Average | 3.6155 |
| 10-Day Moving Average | 3.439 |
| Average True Range | 0.3057 |
| ADX | 18.81 |
| +DI | 12.8878 |
| -DI | 25.0047 |
| Chandelier Exit (Long, 3 ATRs ) | 3.4529 |
| Chandelier Exit (Short, 3 ATRs ) | 3.9971 |
| Upper Bollinger Band | 4.0842 |
| Lower Bollinger Band | 3.1468 |
| Percent B (%b) | -0.04 |
| BandWidth | 25.927258 |
| MACD Line | -0.1298 |
| MACD Signal Line | -0.0887 |
| MACD Histogram | -0.0411 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 3.53 | ||||
| Resistance 3 (R3) | 3.58 | 3.48 | 3.46 | ||
| Resistance 2 (R2) | 3.48 | 3.38 | 3.46 | 3.44 | |
| Resistance 1 (R1) | 3.30 | 3.31 | 3.25 | 3.25 | 3.41 |
| Pivot Point | 3.20 | 3.20 | 3.18 | 3.18 | 3.20 |
| Support 1 (S1) | 3.02 | 3.10 | 2.97 | 2.97 | 2.81 |
| Support 2 (S2) | 2.92 | 3.03 | 2.90 | 2.78 | |
| Support 3 (S3) | 2.74 | 2.92 | 2.76 | ||
| Support 4 (S4) | 2.69 |
